Valuation Iqvia Holdings Inc.

Equities

Market Closed - Nyse Other stock markets 21:00:03 06/03/2026 GMT			5-day change	1st Jan Change
174.49 ^USD	-2.25%		-2.42%	-22.59%

03-06	Argus Research Adjusts IQVIA Holdings PT to $215 From $230, Maintains Buy Rating	MT
03-06	Barclays Upgrades IQVIA Holdings to Overweight From Equal Weight, $210 Price Target	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	53,900	38,056	42,227	35,667	38,387	29,291	-	-
Change	-	-29.39%	10.96%	-15.54%	7.63%	-23.7%	-	-
Enterprise Value (EV) ¹	64,659	49,587	54,524	47,948	52,131	42,368	41,517	40,087
Change	-	-23.31%	9.96%	-12.06%	8.73%	-18.73%	-2.01%	-3.44%
P/E ratio	57x	35.8x	31.7x	26.2x	28.8x	21.2x	17.8x	15.1x
PBR	9.11x	6.6x	7.05x	5.94x	5.96x	3.8x	3.25x	2.76x
PEG	-	2.3x	1.2x	9.55x	6.16x	4.07x	0.9x	0.9x
Capitalization / Revenue	3.88x	2.64x	2.82x	2.32x	2.35x	1.7x	1.6x	1.51x
EV / Revenue	4.66x	3.44x	3.64x	3.11x	3.2x	2.46x	2.27x	2.07x
EV / EBITDA	21.4x	14.8x	15.3x	13x	13.8x	10.6x	9.73x	8.79x
EV / EBIT	25x	17.8x	17.9x	15.5x	23.9x	16.1x	14.1x	12.1x
EV / FCF	28.1x	31.3x	36.3x	22.7x	25.4x	18.7x	17.2x	15.3x
FCF Yield	3.56%	3.2%	2.75%	4.41%	3.93%	5.36%	5.8%	6.53%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	4.95	5.72	7.29	7.49	7.84	8.248	9.798	11.53
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	13,874	14,410	14,984	15,405	16,310	17,241	18,250	19,358
EBITDA ¹	3,022	3,346	3,569	3,684	3,788	4,000	4,265	4,558
EBIT ¹	2,591	2,779	3,050	3,100	2,182	2,639	2,938	3,313
Net income ¹	966	1,091	1,358	1,373	1,360	1,449	1,680	1,967
Net Debt ¹	10,759	11,531	12,297	12,281	13,744	13,077	12,226	10,796
Reference price ²	282.14	204.89	231.38	196.51	225.41	174.49	174.49	174.49
Nbr of stocks (in thousands)	191,040	185,740	182,500	181,500	170,300	167,866	-	-
Announcement Date	15/02/22	10/02/23	14/02/24	06/02/25	05/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
IQVIA HOLDINGS INC.	21.15x	2.46x	10.59x	-.--%	29.29B
LONZA GROUP AG	35.29x	5.14x	17.22x	0.97%	45.49B
BEONE MEDICINES AG	54.35x	4.68x	31.54x	-.--%	33.41B
CELLTRION, INC.	56.43x	11.55x	32.31x	0.34%	31.32B
REVOLUTION MEDICINES, INC.	-12.85x	316.85x	-10.88x	-.--%	19.5B
ASCENDIS PHARMA A/S	45.29x	8.68x	30.73x	-.--%	14.77B
MEDPACE HOLDINGS, INC.	27.52x	4.39x	19.99x	-.--%	13.36B
EUROFINS SCIENTIFIC SE	21.12x	1.94x	8.48x	1.17%	13.22B
IONIS PHARMACEUTICALS, INC.	-18.31x	14.28x	-19.9x	-.--%	12.23B
Average	25.56x	41.11x	13.34x	0.28%	23.62B
Weighted average by Cap.	31.28x	34.76x	16.64x	0.33%